| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes
|
Mirahmadizadeh, Alireza
|
|
|
11 |
2 |
p. 479-494
|
article
|
| 2 |
Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes
|
Mirahmadizadeh, Alireza
|
|
|
11 |
2 |
p. 479-494
|
article
|
| 3 |
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
|
Fadini, Gian Paolo
|
|
|
11 |
2 |
p. 423-436
|
article
|
| 4 |
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
|
Fadini, Gian Paolo
|
|
|
11 |
2 |
p. 423-436
|
article
|
| 5 |
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
|
Romera, Irene
|
|
|
11 |
2 |
p. 437-451
|
article
|
| 6 |
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
|
Romera, Irene
|
|
|
11 |
2 |
p. 437-451
|
article
|
| 7 |
Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
|
Pieber, Thomas R.
|
|
|
11 |
2 |
p. 561-567
|
article
|
| 8 |
Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
|
Pieber, Thomas R.
|
|
|
11 |
2 |
p. 561-567
|
article
|
| 9 |
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
|
Evans, Marc
|
|
|
11 |
2 |
p. 571
|
article
|
| 10 |
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
|
Evans, Marc
|
|
|
11 |
2 |
p. 571
|
article
|
| 11 |
Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
|
Li, Yu-peng
|
|
|
11 |
2 |
p. 569-570
|
article
|
| 12 |
Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
|
Li, Yu-peng
|
|
|
11 |
2 |
p. 569-570
|
article
|
| 13 |
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
|
Emery, Corinne
|
|
|
11 |
2 |
p. 535-548
|
article
|
| 14 |
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
|
Emery, Corinne
|
|
|
11 |
2 |
p. 535-548
|
article
|
| 15 |
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study
|
Tankova, Tsvetalina
|
|
|
11 |
2 |
p. 453-465
|
article
|
| 16 |
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study
|
Tankova, Tsvetalina
|
|
|
11 |
2 |
p. 453-465
|
article
|
| 17 |
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
|
Mathieu, Chantal
|
|
|
11 |
2 |
p. 495-507
|
article
|
| 18 |
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
|
Mathieu, Chantal
|
|
|
11 |
2 |
p. 495-507
|
article
|
| 19 |
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
|
Hidvégi, Tibor
|
|
|
11 |
2 |
p. 467-478
|
article
|
| 20 |
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
|
Hidvégi, Tibor
|
|
|
11 |
2 |
p. 467-478
|
article
|
| 21 |
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
|
Janež, Andrej
|
|
|
11 |
2 |
p. 387-409
|
article
|
| 22 |
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
|
Janež, Andrej
|
|
|
11 |
2 |
p. 387-409
|
article
|
| 23 |
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
|
Yamamoto, Fumiko
|
|
|
11 |
2 |
p. 523-533
|
article
|
| 24 |
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
|
Yamamoto, Fumiko
|
|
|
11 |
2 |
p. 523-533
|
article
|
| 25 |
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
|
Williams, David M.
|
|
|
11 |
2 |
p. 369-386
|
article
|
| 26 |
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
|
Williams, David M.
|
|
|
11 |
2 |
p. 369-386
|
article
|
| 27 |
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
|
Takeshita, Yumie
|
|
|
11 |
2 |
p. 549-560
|
article
|
| 28 |
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
|
Takeshita, Yumie
|
|
|
11 |
2 |
p. 549-560
|
article
|
| 29 |
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
|
Vidal, Josep
|
|
|
11 |
2 |
p. 509-521
|
article
|
| 30 |
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
|
Vidal, Josep
|
|
|
11 |
2 |
p. 509-521
|
article
|
| 31 |
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel
|
Kalra, Sanjay
|
|
|
11 |
2 |
p. 411-422
|
article
|
| 32 |
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel
|
Kalra, Sanjay
|
|
|
11 |
2 |
p. 411-422
|
article
|
Journal description